Source link : https://www.newshealth.biz/health-news/fda-oks-subcutaneous-atezolizumab-for-multiple-cancers/
The US Food and Drug Administration (FDA) has approved atezolizumab and hyaluronidase-tqjs (Tecentriq Hybreza, Genentech, Inc.) as a subcutaneous injection in adults, covering all approved indications of the intravenous (IV) formulation. Approved indications include non–small-cell lung cancer (NSCLC), small-cell lung cancer, hepatocellular carcinoma, melanoma, and alveolar soft part sarcoma. Specific indications are available with the […]
Author : News Health
Publish date : 2024-09-16 07:30:23
Copyright for syndicated content belongs to the linked Source.
Categories